BibTex RIS Kaynak Göster

Ghrelin, resistin and leptin levels in patients with metabolic syndrome

Yıl 2011, Cilt: 8 Sayı: 2, 92 - 97, 01.06.2011

Fatih Koc Mehmet Tokac Volkan Kocabas Coskun Kaya Sadik Buyukbas Sami Erdem Turgut Karabag Kenan Demir Yusuf Alihanoglu Ahmet Kaya

Öz

Anahtar Kelimeler

-

Kaynakça

  • Rabe K, Lehrke M, Parhofer KG, et al. Adipokines and in- sulin resistance. Mol Med 2008;14:741-51.
  • Hamdy O, Ledbury S, Mullooly C, et al. Lifestyle modi- fication improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003;26:2119-25.
  • Ukkola O and Bouchard C. Clustering of metabolic abnor- malities in obese individuals: the role of genetic factors. Ann Med 2001;33:79-90.
  • Matsuzawa Y, Funahashi T, Nakamura T. Molecular mech- anism of metabolic syndrome X: contribution of adipocy- tokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999;892:146-54.
  • Kojima M and Kangawa K. Ghrelin: structure and func- tion. Physiol Rev 2005;85:495-22.
  • Luis DA, Aller R, Izaola O, et al. Influence of insulin resistance and adipocytokines on elevated serum ala- nine aminotransferase in obese patients. Arch Med Res 2008;39:110-14.
  • Ukkola O, Pöykkö SM, Antero Kesäniemi Y. Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Ann Med 2006;38:274-79.
  • Nogueiras R, Tschöp MH, Zigman JM. Central nervous system regulation of energy metabolism: ghrelin versus leptin. Ann N Y Acad Sci 2008;1126:14-9.
  • Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-95.
  • Ukkola O, Poykko S, Paivansalo M, et al. Interactions between ghrelin, leptin and IGF-I affect metabolic syn- drome and early atherosclerosis. Ann Med 2008;29:1-9.
  • Savino F, Liguori SA. Update on breast milk hormones: leptin, ghrelin and adiponectin. Clin Nutr 2008;27:42-7.
  • Schur EA, Cummings DE, Callahan HS, et al. Association of cognitive restraint with ghrelin, leptin, and insulin levels in subjects who are not weight-reduced. Physiol Behav 2008;93:706-12.
  • Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an en- dogenous growth hormone secretagogue, is a novel orexi- genic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001;50:227-32.
  • Chu S, Ding W, Li K, et al. Plasma resistin associated with myocardium injury in patients with acute coronary syn- drome. Circ J 2008;72:1249-53.
  • Savage DB, Sewter CP, Klenk ES, et al. Resistin / Fizz3 ex- pression in relation to obesity and peroxisome prolifera- tor-activated receptor-gamma action in humans. Diabetes 2001;50:2199-202.
  • Bideci A, Camurdan MO, Yeşilkaya E, et al. Serum ghrelin, leptin and resistin levels in adolescent girls with polycys- tic ovary syndrome. J Obstet Gynaecol Res 2008;34:578- 84.
  • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
  • Yingzhong Y, Droma Y, Rili G, et al. Regulation of body weight by leptin, with special reference to hypoxia-in- duced regulation. Intern Med 2006;45:941-46.
  • Yoshinaga M, Sameshima K, Tanaka Y. Adipokines and the prediction of the accumulation of cardiovascular risk fac- tors or the presence of metabolic syndrome in elemen- tary school children. Circ J 2008;72:1874-78.
  • Daghestani MH, Ozand PT, Al-Himadi AR, et al. Hormonal levels of leptin, insulin, ghrelin, and neuropeptide Y in lean, overweight, and obese Saudi females. Saudi Medical Journal 2007;28:1191-97.
  • Tschop M, Weyer C, Tatarannı PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-09.
  • Park HS, Lee KU, Kim YS, et al. Relationships between fasting plasma ghrelin levels and metabolic parameters in children and adolescents. Metabolism 2005;54:925-29.
  • Monti V, Carlson JJ, Hunt SC, et al. Relationship of ghre- lin and leptin hormones with body mass index and waist circumference in a random sample of adults. J Am Diet Assoc 2006;106:822-28.
  • Ikezaki A, Hosoda H, Ito K et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and ado- lescents. Diabetes 2002;51:3408-11.
  • Verma S, Li SH, Wang CH et al. Resistin promotes endo- thelial cell activation: Further evidence of adipokine-en- dothelial interaction. Circulation 2003;108:736-40.
  • Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflam- matory marker of atherosclerosis in humans. Circulation 2005;111:932-39.

Ghrelin, resistin and leptin levels in patients with metabolic syndrome

Yıl 2011, Cilt: 8 Sayı: 2, 92 - 97, 01.06.2011

Fatih Koc Mehmet Tokac Volkan Kocabas Coskun Kaya Sadik Buyukbas Sami Erdem Turgut Karabag Kenan Demir Yusuf Alihanoglu Ahmet Kaya

Öz

-

Anahtar Kelimeler

-

Kaynakça

  • Rabe K, Lehrke M, Parhofer KG, et al. Adipokines and in- sulin resistance. Mol Med 2008;14:741-51.
  • Hamdy O, Ledbury S, Mullooly C, et al. Lifestyle modi- fication improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003;26:2119-25.
  • Ukkola O and Bouchard C. Clustering of metabolic abnor- malities in obese individuals: the role of genetic factors. Ann Med 2001;33:79-90.
  • Matsuzawa Y, Funahashi T, Nakamura T. Molecular mech- anism of metabolic syndrome X: contribution of adipocy- tokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999;892:146-54.
  • Kojima M and Kangawa K. Ghrelin: structure and func- tion. Physiol Rev 2005;85:495-22.
  • Luis DA, Aller R, Izaola O, et al. Influence of insulin resistance and adipocytokines on elevated serum ala- nine aminotransferase in obese patients. Arch Med Res 2008;39:110-14.
  • Ukkola O, Pöykkö SM, Antero Kesäniemi Y. Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Ann Med 2006;38:274-79.
  • Nogueiras R, Tschöp MH, Zigman JM. Central nervous system regulation of energy metabolism: ghrelin versus leptin. Ann N Y Acad Sci 2008;1126:14-9.
  • Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-95.
  • Ukkola O, Poykko S, Paivansalo M, et al. Interactions between ghrelin, leptin and IGF-I affect metabolic syn- drome and early atherosclerosis. Ann Med 2008;29:1-9.
  • Savino F, Liguori SA. Update on breast milk hormones: leptin, ghrelin and adiponectin. Clin Nutr 2008;27:42-7.
  • Schur EA, Cummings DE, Callahan HS, et al. Association of cognitive restraint with ghrelin, leptin, and insulin levels in subjects who are not weight-reduced. Physiol Behav 2008;93:706-12.
  • Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an en- dogenous growth hormone secretagogue, is a novel orexi- genic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001;50:227-32.
  • Chu S, Ding W, Li K, et al. Plasma resistin associated with myocardium injury in patients with acute coronary syn- drome. Circ J 2008;72:1249-53.
  • Savage DB, Sewter CP, Klenk ES, et al. Resistin / Fizz3 ex- pression in relation to obesity and peroxisome prolifera- tor-activated receptor-gamma action in humans. Diabetes 2001;50:2199-202.
  • Bideci A, Camurdan MO, Yeşilkaya E, et al. Serum ghrelin, leptin and resistin levels in adolescent girls with polycys- tic ovary syndrome. J Obstet Gynaecol Res 2008;34:578- 84.
  • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
  • Yingzhong Y, Droma Y, Rili G, et al. Regulation of body weight by leptin, with special reference to hypoxia-in- duced regulation. Intern Med 2006;45:941-46.
  • Yoshinaga M, Sameshima K, Tanaka Y. Adipokines and the prediction of the accumulation of cardiovascular risk fac- tors or the presence of metabolic syndrome in elemen- tary school children. Circ J 2008;72:1874-78.
  • Daghestani MH, Ozand PT, Al-Himadi AR, et al. Hormonal levels of leptin, insulin, ghrelin, and neuropeptide Y in lean, overweight, and obese Saudi females. Saudi Medical Journal 2007;28:1191-97.
  • Tschop M, Weyer C, Tatarannı PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-09.
  • Park HS, Lee KU, Kim YS, et al. Relationships between fasting plasma ghrelin levels and metabolic parameters in children and adolescents. Metabolism 2005;54:925-29.
  • Monti V, Carlson JJ, Hunt SC, et al. Relationship of ghre- lin and leptin hormones with body mass index and waist circumference in a random sample of adults. J Am Diet Assoc 2006;106:822-28.
  • Ikezaki A, Hosoda H, Ito K et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and ado- lescents. Diabetes 2002;51:3408-11.
  • Verma S, Li SH, Wang CH et al. Resistin promotes endo- thelial cell activation: Further evidence of adipokine-en- dothelial interaction. Circulation 2003;108:736-40.
  • Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflam- matory marker of atherosclerosis in humans. Circulation 2005;111:932-39.
Toplam 26 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Makaleler
Yazarlar

Fatih Koc Bu kişi benim

Mehmet Tokac Bu kişi benim

Volkan Kocabas Bu kişi benim

Coskun Kaya Bu kişi benim

Sadik Buyukbas Bu kişi benim

Sami Erdem Bu kişi benim

Turgut Karabag Bu kişi benim

Kenan Demir Bu kişi benim

Yusuf Alihanoglu Bu kişi benim

Ahmet Kaya Bu kişi benim

Yayımlanma Tarihi 1 Haziran 2011
Yayımlandığı Sayı Yıl 2011 Cilt: 8 Sayı: 2

Kaynak Göster

APA Koc, F., Tokac, M., Kocabas, V., Kaya, C., vd. (2011). Ghrelin, resistin and leptin levels in patients with metabolic syndrome. European Journal of General Medicine, 8(2), 92-97.
AMA Koc F, Tokac M, Kocabas V, Kaya C, Buyukbas S, Erdem S, Karabag T, Demir K, Alihanoglu Y, Kaya A. Ghrelin, resistin and leptin levels in patients with metabolic syndrome. European Journal of General Medicine. Haziran 2011;8(2):92-97.
Chicago Koc, Fatih, Mehmet Tokac, Volkan Kocabas, Coskun Kaya, Sadik Buyukbas, Sami Erdem, Turgut Karabag, Kenan Demir, Yusuf Alihanoglu, ve Ahmet Kaya. “Ghrelin, Resistin and Leptin Levels in Patients With Metabolic Syndrome”. European Journal of General Medicine 8, sy. 2 (Haziran 2011): 92-97.
EndNote Koc F, Tokac M, Kocabas V, Kaya C, Buyukbas S, Erdem S, Karabag T, Demir K, Alihanoglu Y, Kaya A (01 Haziran 2011) Ghrelin, resistin and leptin levels in patients with metabolic syndrome. European Journal of General Medicine 8 2 92–97.
IEEE F. Koc, “Ghrelin, resistin and leptin levels in patients with metabolic syndrome”, European Journal of General Medicine, c. 8, sy. 2, ss. 92–97, 2011.
ISNAD Koc, Fatih vd. “Ghrelin, Resistin and Leptin Levels in Patients With Metabolic Syndrome”. European Journal of General Medicine 8/2 (Haziran 2011), 92-97.
JAMA Koc F, Tokac M, Kocabas V, Kaya C, Buyukbas S, Erdem S, Karabag T, Demir K, Alihanoglu Y, Kaya A. Ghrelin, resistin and leptin levels in patients with metabolic syndrome. European Journal of General Medicine. 2011;8:92–97.
MLA Koc, Fatih vd. “Ghrelin, Resistin and Leptin Levels in Patients With Metabolic Syndrome”. European Journal of General Medicine, c. 8, sy. 2, 2011, ss. 92-97.
Vancouver Koc F, Tokac M, Kocabas V, Kaya C, Buyukbas S, Erdem S, Karabag T, Demir K, Alihanoglu Y, Kaya A. Ghrelin, resistin and leptin levels in patients with metabolic syndrome. European Journal of General Medicine. 2011;8(2):92-7.